title: Glycine agonists: what can they teach us about schizophrenia?
authors.affiliation: Department of Psychiatry, Washington University, St. Louis, MO 63110, USA.
authors.forename: N B
authors.initials: NB
authors.lastname: Farber
authors.forename: J W
authors.initials: JW
authors.lastname: Newcomer
authors.forename: J W
authors.initials: JW
authors.lastname: Olney
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002648:Child; D002986:Clinical Trials as Topic; D003523:Cycloserine / Q000494:pharmacology / Q000627:therapeutic use; D005998:Glycine / Q000819:agonists* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D012565:Schizophrenic Psychology
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D003523:Cycloserine; D005998:Glycine